To the Chinese capital, the dawn of November long meant one thing -- the invasion of winter cabbage, the government-subsidized, not-too-tasty "patriotic vegetable" that sustained the masses through the icy months. \nRickety trucks from one-horse towns streamed into the city, laden with heads of da baicai -- big cabbage. Folks queued their donkey carts and wheelbarrows, anxiously stocking up. Refrigeratorless families by the millions lined gray rooftops with edible green shingles. \nThis week, the cabbages are coming, right on schedule. But it's not like it used to be. \nWith each November's passing, the fuel of the proletarian revolution is becoming simply another lifestyle choice in a shiny city of dizzying selections. And therein lies a tale -- of economic progress, increasing affluence, and a generation of palates weaned on Pizza Hut. \n"Old grandpas still fondly remember da baicai. But for people my age, it's just like any other vegetable," said Dong Yue, 34. He oversees marketing for Dayanglu, one of Beijing's largest wholesale produce markets. Its inventory this week includes 109 varieties of vegetables. \nIn recent days, vendors from all corners of the land have brought their perishable harvests to Dayanglu for the pre-winter rush. Color is splashed everywhere: scarlet bell peppers, emerald hot peppers, eggplants in deep purple. \nArmed with the inventory of available vegetables, Dong ticks off those that many farmers hadn't heard of a decade ago. When he's done, 50 of the 109 items are checked -- everything from iceberg lettuce to celery to the more exotic "monkey-head mushrooms." \n"Lines for da baicai? You won't see that anymore," said Gao Zhanmin, laughing as his half-full truck of cabbages loomed behind him. "They want one bunch, they just go out and buy it. They don't need to fill their homes with it anymore." \nTwenty years ago, 95 percent of sales at Beijing's wholesale produce markets came from da baicai. Ten years ago, it was between 50 and 70 percent. This year, Dong expects just 9 percent of Dayanglu's sales to come from the cabbage. \nOn Monday, the government's Xinhua News Agency said demand for da baicai -- known to most Americans as Napa cabbage or by its Cantonese name, bok choy -- was expected to plummet yet again, this time by 8.3 percent from last year. \n"The house vegetable of Beijing has lost its vaunted position," Xinhua said with a whiff of lament. \nIt's hardly disappearing: In 2001, the average Beijing resident consumed 35kg of the cabbage. But China's two-decade experiment in capitalism has brought extraordinary changes to everyday life, and even to cabbage. \nWhen economic reform began in the late 1970s, Beijing was emerging from Mao Zedong's (毛澤東) Cultural Revolution. Restaurants, scorned for years as bourgeois, were rare. Among winter's few certainties were the odor of burning coal, the wizened men on street corners selling sunflower seeds from burlap sacks, and the cabbage. \nDa baicai became Beijing's culinary canvas. There was cabbage in sour sauce. Cabbage soup. Cabbage and bean curd. Braised cabbage over rice. And on special days, cabbage dumplings -- sometimes with a bit of minced pork. \n"There were no other vegetables. And no one could have afforded them anyway," said Ma Laicang, owner of the Old Beijing Zhajiang Noodle King, a restaurant offering several cabbage dishes. \nA 1988 shortage caused panic buying, and a glut the following year left 80,000 tonnes of cabbage piled in the streets. The mayor invoked patriotism and ordered public offices, schools, factories and army units to stock up. The cabbage crisis ebbed. \nIn 1992, the government cut its cabbage subsidy. Five years later, it deregulated the price. Popularity plummeted. Why hoard cabbage when so many other delicacies were available? \nIn today's Beijing, the French superstore Carrefour sells fresh-squeezed grapefruit juice, nine varieties of mushrooms and an entire aisle of canned vegetables -- a sharp contrast to Beijing of 1980, when an average Chinese couldn't buy a Coca-Cola without knowing a foreigner.
The COVID-19 variant discovered in South Africa can “break through” Pfizer-BioNTech’s COVID-19 vaccine to some extent, a real-world data study released on Saturday found, although its prevalence in the country is low and the research has not been peer reviewed. The study in Israel compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated people with the disease. It matched age and gender, among other characteristics. The South African variant, B.1.351, was found to make up about 1 percent of all the COVID-19
RARE ADMISSION: A top Chinese expert was the first to publicly address the efficacy of the nation’s vaccines as it aims to inoculate 40 percent of its population by June China is considering mixing different COVID-19 vaccines to improve the relatively low efficacy of its existing options, a top health expert told a conference in Chengdu on Saturday. Authorities have to “consider ways to solve the issue that efficacy rates of existing vaccines are not high,” Chinese media outlet The Paper reported, citing Chinese Center for Disease Control and Prevention Director Gao Fu (高福). His comments mark the first time a top Chinese expert has publicly alluded to the relatively low efficacy of the country’s vaccines, as China forges ahead in its mass vaccination campaign and exports its jabs around the world. China
The Australian government yesterday said that it had decided against buying the single-dose Johnson & Johnson (J&J) COVID-19 vaccine and identified a second case of a rare blood clot likely linked to the AstraZeneca shot. The Australian government had been in talks with the New Jersey-based pharmaceutical giant, which had asked the Australian Therapeutic Goods Administration for provisional registration. However, Australian Minister of Health Greg Hunt ruled out a J&J contract, because its vaccine was similar to the AstraZeneca product, which Australia had already contracted for 53.8 million doses. Hunt said the government was following the advice of Australia’s scientific and technical advisory
The Indonesian government has said it is satisfied with the effectiveness of the Chinese COVID-19 vaccine it has been using, after China’s top disease control official said that current vaccines offer low protection against the novel coronavirus. Siti Nadia Tarmizi, a spokesperson for Indonesia’s COVID-19 vaccine program, on Monday said the WHO had found that the Chinese vaccines had met requirements by being more than 50 percent effective. Clinical trials in Indonesia for the vaccine from Chinese drugmaker Sinovac showed that it was 65 percent effective, she said. “It means ... the ability to form antibodies in our bodies is still very